Akorn subsidiary gets FDA approval for ANDA for loteprednol etabonate
The approval for 207609 for a generic version of loteprednol etabonate, which is sold in branded form under the name Lotemax, was granted on April 17 to Hi-Tech Pharmacal, an Akorn company, according to a post to the FDA website.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.